NCT02559869View on ClinicalTrials.gov

Imaging and BioFluid Biomarkers in Amyotrophic Lateral Sclerosis

CompletedOBSERVATIONAL
Enrollment

86

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

June 28, 2019

Study Completion Date

June 28, 2019

Conditions
Amyotrophic Lateral Sclerosis (ALS)
Interventions
DRUG

[18F] GE-180

PET Tracer Ligand

Trial Locations (2)

77030

Houston Methodist Hospital, Houston

02114

Massachusetts General Hospital, Boston

All Listed Sponsors
collaborator

The Methodist Hospital Research Institute

OTHER

collaborator

Cedars-Sinai Medical Center

OTHER

collaborator

ALS Association

OTHER

lead

Massachusetts General Hospital

OTHER

NCT02559869 - Imaging and BioFluid Biomarkers in Amyotrophic Lateral Sclerosis | Biotech Hunter | Biotech Hunter